Prior to this round, the company has raised capital from Accel, Chiratae Ventures, University of California–Ratan Tata Fund, and Omidyar Network India, Axio Biosolution said in a statement
Axio Biosolutions had raised $7.4 million in a series B funding round led by Ratan Tata’s UC- RNT, along with existing investors Accel Partners and IDG Ventures India.
Funded by Accel Partners, IDG Ventures and GVFL, Axio is a global name that uses innovative medical technology to create breakthrough products and save people’s lives.